¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Respiratory failure of newborn"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 2
¿µ¹® severe acute respiratory syndrome(SARS) ÇÑ±Û ÁßÁõ±Þ¼ºÈ£ÈíÁõÈıº
¼³¸í   
  Áß±¹ ±¤µ¿ Áö¿ª¿¡¼­ °¡Àå ¸ÕÀú ¹ß»ýÇÑ Àü¿°¼ºÈ£Èí±âº´À¸·Î ¼¼°èº¸°Ç±â±¸(WHO)¿¡¼­ ¡®ÁßÁõ±Þ¼ºÈ£ÈíÁõÈıº(SARS)'À¸·Î ¸í¸íÇß´Ù. ¼·¾¾ 38µµ ÀÌ»óÀÇ °í¿­°ú ±âħ, È£Èí°ï¶õ, Àú»ê¼ÒÁõ, X¼±»óÀÇ Æó·ÅÁõ»ó Áß Çϳª ÀÌ»óÀÇ Áõ»óÀÌ ³ªÅ¸³ª¸ç, µÎÅë, ±ÙÀ°Åë, ½Ä¿åºÎÁø, ÇǷΰ¨, ¹ßÁø, ¼³»ç¸¦ µ¿¹ÝÇÒ ¼ö ÀÖ´Ù. Ãʱâ Áõ»óÀº °¨±â¿Í ºñ½ÁÇÏÁö¸¸ Æó·ÅÀ¸·Î ¹ßÀüÇϸé Ä¡¸íÀûÀÏ ¼ö ÀÖ´Ù. ÇöÀç ¹àÇôÁø °¨¿°°æ·Î´Â È¯ÀÚ°¡ Àçä±â³ª ±âħÇÒ ¶§ ³»»Õ´Â Ä§¹æ¿ïÀ̰í, À̰ÍÀÌ ´Ù¸¥ »ç¶÷ÀǠȣÈí±â·Î µé¾î°¥ ¶§ Àü¿°µÈ´Ù. Ä§¹æ¿ïÀÌ Àü´ÞµÇ´Â °Å¸®´Â º¸Åë 1m·Î º¸°í ÀÖ´Ù. °ø±â¸¦ ÅëÇØ Àü¿°ÀÌ °¡´ÉÇϴٴ ÁÖÀåÀÌ Á¦±âµÆÁö¸¸ ¾ÆÁ÷ È®ÀεÇÁö ¾Ê¾Ò´Ù. ¿øÀαÕÀº º¯Á¾ Äڷγª¹ÙÀÌ·¯½º·Î ¹àÇôÁ³´Ù.
¿µ¹® respiratory distress syndrome(RDS) ÇÑ±Û È£Èí°ï¶õÁõÈıº
¼³¸í   
  ÆóÆ÷¿Í Æó¸ð¼¼Ç÷°ü »çÀÌ¿¡ ºÎÁ¾À¸·Î ÀÎÇÑ È®»ê´É °¨¼Ò·Î È£Èí°ï¶õ°ú Ã»»öÁõÀ» º¸À̴ »óÅ·Π°¨¿°, ¼ö¼ú, ¿Ü»ó µî ¸ðµç Á¾·ùÀÇ ½ºÆ®·¹½º»óȲ¿¡¼­ ¹ß»ýÇÒ ¼ö ÀÖ´Ù. Ä¡·á´Â ¼±Çà ¿äÀÎÀÇ ±³Á¤°ú ÀûÀýÇÑ Ç÷¾×³» »ê¼Ò³óµµ À¯ÁöÀÌ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • forward heart failure
    ¾ÕÂʽÉÀå±â´É»ó½Ç, ÀüÇâ½É(Àå)ºÎÀü
  • fulminant hepatic failure
    Àü°Ý°£±â´É»ó½Ç
  • growth failure
    ¹ßÀ°ºÎÀü, ¼ºÀåºÎÀü
  • hypodiastolic failure
    ÀúÈ®Àå±â½ÉÀå±â´É»ó½Ç, ÀúÈ®Àå±â½ÉºÎÀü
  • hypoxic heart failure
    Àú»ê¼Ò½ÉÀå±â´É»ó½Ç, Àú»ê¼Ò½É(Àå)ºÎÀü
  • heart failure
    ½ÉÀå±â´É»ó½Ç, ½ÉºÎÀü
  • heart failure cell
    ½ÉºÎÀü¼¼Æ÷
  • hemostatic failure
    ÁöÇ÷±â´É»ó½Ç
  • high-output heart failure
    °í¹ÚÃâ½ÉÀå±â´É»ó½Ç, °í¹ÚÃâ½É(Àå)ºÎÀü
  • intractable heart failure
    ³­Ä¡½ÉÀå±â´É»ó½Ç, ³­Ä¡½É(Àå)ºÎÀü
  • left sided heart failure
    ¿Þ½ÉÀå±â´É»ó½Ç, Á½ÉÀåºÎÀü
  • left ventricular failure
    ¿Þ½É½Ç±â´É»ó½Ç, Á½ɽǺÎÀü
  • low-output heart failure
    Àú¹ÚÃâ½ÉÀå±â´É»ó½Ç, Àú¹ÚÃâ½É(Àå)ºÎÀü
  • myocardial failure
    ½É±Ù±â´É»ó½Ç, ½É±ÙºÎÀü
  • ovarian failure
    ³­¼Ò±â´É»ó½Ç
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • respiratory insufficiency
    È£Èí±â´ÉºÎÁ·
  • respiratory mucosa
    È£ÈíÁ¡¸·
  • respiratory nerve
    È£Èí½Å°æ
  • respiratory organ
    È£Èí±â°ü
  • respiratory obstruction
    ±âµµ¸·Èû, È£ÈíÆó¼â
  • respiratory quotient
    È£ÈíÁö¼ö, È£Èí»ó¼ö
  • respiratory rate
    È£Èí¼öÈ£Èí·ü
  • respiratory substrate
    È£Èí±âÁú
  • respiratory system
    È£Èí°èÅë
  • respiratory stimulant
    È£ÈíÀÚ±ØÁ¦
  • respiratory stenosis
    ±âµµÇùÂø(Áõ)
  • respiratory standstill
    È£ÈíÁ¤Áö
  • respiratory distress syndrome
    È£Èí°ï¶õÁõÈıº
  • respiratory disturbance syndrome
    È£ÈíÀå¾ÖÁõÈıº
  • severe acute respiratory syndrome
    ÁßÁõ±Þ¼ºÈ£ÈíÁõÈıº
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • heart failure
    ½ÉÀå±â´É»ó½Ç, ½ÉÀåºÎÀü
  • high-output heart failure
    °í¹ÚÃâ½ÉÀå±â´É»ó½Ç, °í¹ÚÃâ½ÉÀåºÎÀü
  • hypodiastolic failure
    ÀúÈ®Àå±â½ÉÀå±â´É»ó½Ç, ÀúÈ®Àå±â½ÉºÎÀü
  • hypoxic heart failure
    Àú»ê¼Ò½ÉÀå±â´É»ó½Ç, Àú»ê¼Ò½ÉÀåºÎÀü
  • intractable heart failure
    ³­Ä¡½ÉÀå±â´É»ó½Ç, ³­Ä¡½ÉÀåºÎÀü
  • left sided heart failure
    (¢¡left ventricular failure) ¿Þ½É½Ç±â´É»ó½Ç, Á½ɽǺÎÀü
  • left ventricular failure
    ¿Þ½É½Ç±â´É»ó½Ç, Á½ɽǺÎÀü
  • low-output heart failure
    Àú¹ÚÃâ½ÉÀåºÎÀü
  • myocardial failure
    ½É±Ù±â´É»ó½Ç, ½É±ÙºÎÀü
  • right sided heart failure
    (¢¡right ventricular failure) ¿À¸¥½É½Ç±â´É»ó½Ç, ¿ì½É½ÇºÎÀü
  • right ventricular failure
    ¿À¸¥½É½Ç±â´É»ó½Ç, ¿ì½É½ÇºÎÀü
  • ventilatory failure
    ȯ±âºÎÀü, ȯ±â½ÇÆÐ
  • respiratory acidosis
    È£Èí»êÁõ
  • respiratory alkalosis
    È£Èí¾ËÄ«¸®Áõ
  • respiratory apparatus
    È£Èí±â°ü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • acute respiratory illness =ARI
    ±Þ¼º È£Èí±âº´.
  • acute respiratory illness =ARI
    ±Þ¼º È£Èí±âº´.
  • adult respiratory distress syndrome
    ¼ºÀμº È£Èí°ï¶õÁõÈıº(à÷ìÑàõû¼ýåÍÝÑññøý¦ÏØ).
  • adult respiratory distress syndrome(ards)
    ¼ºÀμºÈ£Èí°ï¶õÁõÈıº(à÷ìÑàõû¼ýåÍÝÑññøý¦ÏØ)
  • allergic respiratory disease
    ¾Ë·¹¸£±â¼º È£Èí±âº´
  • ards(adult respiratory disress syndrome)
    ARDS(¼ºÀÎÈ£Èí°ï¶õÁõÈıº)(à÷ìÑû¼ýåÍÝÑññøý¦ÏØ)
  • idiopathic respiratory distress
    Ư¹ß¼º È£Èí°ï¶õ.
  • idiopathic respiratory distress syndrome
    Ư¹ß¼º È£Èí°ï¶õÁõÈıº.
  • pontine respiratory center
    ³ú±³È£ÈíÁßÃß(ÒàÎéû¼ýåñéõÒ).
  • rds=£¾respiratory distress syndrome
    È£Èí°ï¶õÁõÈıº(û¼ýåÍÝÑññøý¦ÏØ)
  • Congestive heart failure
    ¿ïÇ÷¼º(ê¦úìàõ)½ÉºÎÀü(ãýÜôîï)
  • Heart failure
    ½ÉºÎÀü(ãýÜôîï)
  • RFI=>renal failure index
    ½ÅºÎÀüÁö¼ö
  • acute heart failure
    ±Þ¼º ½ÉºÎÀü(¡­ãýÝÕîï).
  • acute renal failure
    ±Þ¼º ½ÅºÎÀü(Áõ)(¡­ãìÝÕîïñø).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • lamellar desquamation of the newborn
    ½Å»ý¾Æ ÆÇ»ó ³«¼³
  • listeriosis of newborn
    ½Å»ý¾Æ(ãæßæä®)¸®½ºÅ׸®¾ÆÁõ.
  • metabolic disturbance, newborn
    ½Å»ý¾Æ´ë»çÀå¾Ö(ãæßæä®ÓÛÞóî¡äô).
  • neonate =newborn
    ½Å»ý¾Æ(ãæßæä®).
  • newborn
    ½Å»ý¾Æ(ãæßæä®)
  • newborn anoxia ³ª a. neonatorum
    ½Å»ý¾Æ ¹«<Àú>»ê¼Ò(Áõ)(ãæßæä®Ùí<î¼>ß«áÈñø).
  • newborn baby
    ½Å»ý¾Æ.
  • newborn infant
    ½Å»ý¾Æ.
  • newborn melena ³ª m. neonatorum
    ½Å»ý¾ÆÇ÷º¯, ½Å»ý¾ÆÇÏÇ÷.
  • newborn resuscitation
    ½Å»ý¾Æ¼Ò»ý(¹ý)(~áÌßæÛö).
  • resuscitation of newborn
    ½Å»ý¾Æ¼Ò»ý¹ý(ãæßæä®áÌßæÛö).
  • subcutaneous fat necrosis of newborn
    ½Å»ý¾ÆÇÇÇÏÁö¹æ±«»ç.
  • subcutaneous fat necrosis of newborn
    ½Å»ý¾ÆÇÇÇÏÁö¹æ±«»ç(ãæßæä®ù«ù»ò·Û¸ÎÕÞÝ)
  • transient hyperammonemia of newborn
  • transient tachypnea of newborn
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • respiratory protein
    È£Èí ´Ü¹éÁú(Ó±ÛÜòõ)
  • respiratory quotient
    È£Èí·ü(û¼ýå×Ë)
  • respiratory reduction
    È£Èí¼º ȯ¿ø(û¼ýåàõü½êª)
  • respiratory repression
    È£Èí ¾ïÁ¦(åäð¤)
  • Warburg's respiratory enzyme
    ¹Ù¸£ºÎ¸£Å© È£ÈíÈ¿¼Ò(û¼ýåý£áÈ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • respiratory capacity
    È£Èí¿ë·®, ÆóȰ·®
  • respiratory center
    È£ÈíÁßÃß
  • respiratory dead space
    È£Èí¼º¹«È¿°ø°£
  • respiratory disease
    È£Èí±âº´, È£Èí°ï¶õ
  • respiratory distress syndrome
    È£Èí°ï¶õÁõÈıº
  • respiratory disturbance
    È£ÈíÀå¾Ö
  • respiratory function
    È£Èí±â´É
  • respiratory function test
    È£Èí±â´É°Ë»ç
  • respiratory gating
    È£Èíµ¿±â
  • respiratory insufficiency
    È£Èí(±â´É)ºÎÀü
  • respiratory obstruction
    ±âµµÆó¼â, È£ÈíÆó¼â
  • respiratory ordered phase encoding
    È£Èí¼øÀ§»óºÎȣȭ
  • respiratory organ
    È£Èí±â
  • respiratory paralysis
    È£Èí¸¶ºñ
  • respiratory tract
    ±âµµ, È£Èí±âµµ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
RC an electronic circuit containing a resistor and capacitor in series; radiocarpal; reaction center; r...
TRDN transient respiratory distress of the newborn
JVP [POMD P 49 - 52]
  1) Jugular Vein Pressure
  2) Jugular Venous Pulse
...
CHF chick embryo fibroblast; chronic heart failure; congenital hepatic fibrosis; congestive heart failur...
RVF renal vascular failure; Rift Valley fever; right ventricular failure; right visual field
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
N.I.C.U. Newborn Intensive Care Unit
NBS Newborn bovine serum
PPHN Persistent Pulmonary Hypertension of the Newborn
UNHS Universal newborn hearing screening
NB newborn
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • left sided heart failure
    ÁÂ½É ºÎÀü
  • left ventricular failure
    Á ½É½Ç ºÎÀü
  • liver failure
    °£ ºÎÀü, °£ ±â´É ºÎÀü
    Áúº´À¸·Î ÀÎÇØ °£ÀÌ Á¦ ±â´ÉÀ» ¼öÇàÇÏÁö ¸øÇÏ´Â »óÅÂ.
  • myocardial failure
    ½É±Ù ºÎÀü
  • potential for surgical failure
    ¿Ü°úÀû Ä¡·áÀÇ ½ÇÆÐ °¡´É¼º
  • primary failure
    ÀÏÂ÷Àû ¹«È¿
  • pulmonary failure
    Æó ºÎÀü
  • renal failure
    ½Å ºÎÀü
  • right auricular failure
    ¿ì¹æ ºÎÀü
  • right ventricular failure
    ¿ì ½É½Ç ºÎÀü
  • transplant failure
    ÀÌ½Ä ½ÇÆÐ
  • accessory respiratory muscle
    º¸Á¶ È£Èí±Ù
    È£ÈíÇÏ´Â µ¥ °¡Àå Áß¿äÇÑ °¡·Î¸· ¿ÜÀÇ ¼û½¬´Â µ¥ º¸Á¶¸¦ ÁÖ´Â °¥ºñ»À »çÀÌ ±ÙÀ° °°Àº °Í.
  • acute respiratory distress syndrome
    ±Þ¼º È£Èí°ï¶õ ÁõÈıº
    ¼ºÀΠȣÈíºÎÀü, ¼ï Æó, ¹Ì¸¸¼º ÆóÆ÷ ¼Õ»ó, ±Þ¼º ÆóÆ÷ ¼Õ»ó, ¿Ü»ó¼º ÀæÀº Æó µîÀÌ ÀÖ´Ù. ¹Ì¸¸¼ºÀ¸·Î ÆóÆ÷ ¸ð¼¼Ç÷°üÀÌ ¼Õ»óÀ» ÀÔ¾î ÃÊ·¡µÇ¸ç ÀÓ»óÀûÀ¸·Î´Â ±Þ°ÝÈ÷ »ý±ä ½ÉÇÑ È£Èí°ï¶õ, ºó¸Æ, û»öÁõ ¹× »ê¼Ò¿ä¹ý¿¡ ¹ÝÀÀÇÏÁö ¾Ê´Â µ¿¸Æ Àú»ê¼ÒÁõ µîÀ» Ư¡À¸·Î ÇÑ´Ù.
  • adult respiratory distress syndrome
    ¼ºÀμº È£Èí°ï¶õ ÁõÈıº
    ¿Ü»ó ¸çÄ¥ ÈÄ¿¡ ¹ß»ýÇÏ´Â °©ÀÛ½º·¯¿î Æó °£Áú ¹× ÆóÆ÷ÀÇ ºÎÁ¾. ÀÌ´Â ³ú ¼Õ»ó ȤÀº Àú»ê¼ÒÁõ¿¡ ÀÇÇØ »ý±â´Â °ú°ÝÇÑ ±³°¨½Å°æ°è Ç×Áø ¶Ç´Â ¸ð¼¼Ç÷°ü Åõ°ú¼ºÀÇ Áõ°¡°¡ ¿øÀÎÀ¸·Î »ý°¢µÈ´Ù.
  • allergic respiratory disease
    ¾Ë·¹¸£±â¼º È£Èí±âº´
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
newborn neonatal, neonate
newborn jaundice <paediatrics> A normal condition of elevated bilirubin in the bloodstream of a newborn.
This occurs secondary to immaturity of liver cells (cannot effectively metabolise bilirubin) and the increased destruction of red blood cells (further releasing bilirubin into the bloodstream) that is normally seen in the newborn.
The jaundice usually appears between the 2nd and 5th days of life and usually clears by 2 weeks. Other factors which can potentiate jaundice in the newborn include: sepsis, biliary atresia, Rhesus incompatibility, galactosaemia, cephalohaematoma, polycythaemia, G-6-P-D deficiency and congenital rubella, syphilis, toxoplasmosis or cytomegalovirus infection.
(10 Jan 1998)
newborn screening Tests of newborns to detect those at increased risk for disorders such as pku (phenylketonuria) and hypothyroidism.
(12 Dec 1998)
subcutaneous fat necrosis of newborn Indurated plaques and nodules appearing usually a few days or a few weeks after birth and usually resolving within a few months, characterised microscopically by birefringent needle-shaped crystals within necrotic fat cells; the condition remains localised, unlike sclerema neonatorum.
(05 Mar 2000)
disease, haemolytic, of the newborn Abnormal breakup of red blood cells in the foetus or newborn.
(12 Dec 1998)
infant, newborn An infant during the first month after birth.
(12 Dec 1998)
infant, newborn, diseases Diseases of newborn infants present at birth (congenital) or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both hereditary diseases and metabolism, inborn errors are available as general concepts.
(12 Dec 1998)
jaundice of the newborn Icterus which can be accentuated by many factors including excessive haemolysis, sepsis, neonatal hepatitis or congenital atresia of the biliary system.
Synonym: physiologic icterus, jaundice of the newborn, neonatal jaundice, physiologic jaundice.
(05 Mar 2000)
leukocytosis of the newborn An apparently "physiologic" leukocytosis usually observed in newborn infants, in whom the white blood cell counts are usually greater than 10,000 per cu mm, and sometimes range to 45,000 per cu mm, resulting chiefly from increased numbers of neutrophils (especially single and bilobed forms). On the third or fourth day of life, the count generally decreases rapidly, and then fluctuates for several days; beginning about the fourth week of life, a relative lymphocytosis is observed, and this normally continues for a few years.
(05 Mar 2000)
acute kidney failure <nephrology> A sudden decline in renal function may be triggered by a number of acute disease processes.
Examples include sepsis (infection), shock, trauma, kidney stones, kidney infection, drug toxicity (aspirin or lithium), poisons or toxins (drug abuse) or after injection with an iodinated contrast dye (adverse effect).
Chronic renal failure represents a slow decline in kidney function over time. Chronic renal failure may be caused by a number of disorders which include long-standing hypertension, diabetes, congestive heart failure, lupus or sickle cell anaemia. Both forms of renal failure result in a life-threatening metabolic derangement.
(27 Sep 1997)
acute renal failure <nephrology> A sudden decline in renal function may be triggered by a number of acute disease processes.
Examples include sepsis (infection), shock, trauma, kidney stones, kidney infection, drug toxicity (aspirin or lithium), poisons or toxins (drug abuse) or after injection with an iodinated contrast dye (adverse effect).
Chronic renal failure represents a slow decline in kidney function over time. Chronic renal failure may be caused by a number of disorders which include long-standing hypertension, diabetes, congestive heart failure, lupus or sickle cell anaemia. Both forms of renal failure result in a life-threatening metabolic derangement.
(27 Sep 1997)
backward heart failure A concept (formerly considered mutually exclusive of forward heart failure) that maintains that the phenomena of congestive heart failure result from passive engorgement of the veins caused by a "backward" rise in pressure proximal to the failing cardiac chambers.
Compare: forward heart failure.
(05 Mar 2000)
cardiac failure A condition where there is ineffective pumping of the heart leading to an accumulation of fluid in the lungs. Typical symptoms include shortness of breath with exertion, difficulty breathing when lying flat and leg or ankle swelling. Causes include chronic hypertension, cardiomyopathy and myocardial infarction.
(27 Sep 1997)
pacemaker failure Failure of an artificial pacemaker to generate or deliver effective stimuli to the myocardium.
(05 Mar 2000)
renal failure Chronic renal failure represents a slow decline in kidney function over time. Chronic renal failure may be caused by a number of disorders which include long-standing hypertension, diabetes, congestive heart failure, lupus or sickle cell anaemia. If renal function declines to a low enough level (end-stage renal disease) kidney dialysis may be necessary. A sudden decline in renal function may be triggered by a number of acute disease processes.
Examples include sepsis (infection), shock, trauma, kidney stones, kidney infection, drug toxicity (aspirin or lithium), poisons or toxins (drug abuse) or after injection with an iodinated contrast dye (adverse effect). Both forms of renal failure result in a life-threatening metabolic derangement.
(27 Sep 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á